A microemulsion co-loaded with Schizandrin A–docetaxel enhances esophageal carcinoma treatment through overcoming multidrug resistance

Multidrug resistance (MDR) is the major underlying cause of the low 5-year survival rate of esophageal carcinoma. In this study, we developed a novel microemulsion system (SD-ME) co-loaded with docetaxel (DTX) and Schizandrin A, a potent chemotherapeutic agent and a potential drug resistance modulat...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Xiangyu Su, Chanchan Gao, Fangfang Shi, Xiaoyao Feng, Lin Liu, Ding Qu, Cailian Wang
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Taylor & Francis Group 2017-01-01
coleção:	Drug Delivery
Assuntos:	docetaxel drug resistance esophageal carcinoma microemulsion schizandrin a
Acesso em linha:	http://dx.doi.org/10.1080/10717544.2016.1225854
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!